Related Experiment Video
Updated: Aug 17, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
[Emphasizing the prevention and treatment for retinopathy of prematurity]
Insights
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness in premature infants receiving oxygen therapy. Its increasing incidence highlights the need for ophthalmologists
Area of Science:
- Ophthalmology
- Neonatology
- Pediatrics
Background:
- Retinopathy of prematurity (ROP), previously known as retrolental fibroplasia, affects premature and low birth weight infants.
- Oxygen therapy is a significant risk factor associated with ROP development.
- ROP is a primary cause of blindness in children within developed nations.
Discussion:
- Advances in perinatal medicine and life support systems have increased the survival rate of premature infants.
- This improved survival correlates with a rising incidence of ROP and associated childhood blindness.
- Ophthalmologists must address the growing public health concern of ROP-induced vision impairment.
Key Insights:
- The article reviews global ROP incidence data, historical prevention and treatment strategies, retinal development, and ROP histopathology.
- It also covers the international classification of ROP and critical treatment timing.
- ROP incidence is linked to Neonatal Intensive Care Unit (NICU) practices and medical legislation.
Outlook:
- Continued research into ROP pathogenesis and treatment is essential.
- Enhanced screening protocols and timely interventions can mitigate ROP-related blindness.
- Multidisciplinary collaboration between neonatologists and ophthalmologists is crucial for managing ROP.
Abstract:
Retinopathy of prematurity (ROP) (previously called retrolental fibroplasia), is a proliferative retinopathy of premature and low birth weight infants related with receiving oxygen therapy. ROP is the leading cause of children blindness in the developed countries. With the improvement of health level in our country, perinatal medicine has obtained much development. With the improvement of life support systems, the survival rate of premature in our country is becoming higher and the incidence of ROP is increasing accordingly. The children blindness caused by this illness is increasing, which should obtain the ophthalmologists highly attention. In this article, we discuss the data of ROP incidence in the world; the history of ROP prevention and treatment; the development of the retina, the histopathology of ROP; the international classification of ROP and the timing limit of treatment of ROP. ROP is the leading cause of children blindness in the developed countries. ROP incidence is related with the NICU's treatment and the application of relevant medical laws.
Related Concept Videos
Diabetic Retinopathy
Preventive Healthcare Services
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
The Retina
Angle Closure Glaucoma: Treatment
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...

